Occlusive Stroke Clinical Trial
Official title:
Safety and Utility Profile of the Asahi Chikai Black 18 neuRovascular guidewirE in Large Vessel Occlusive Stroke: SURE 18 Registry
The objective of this study is to obtain post market data on the Asahi Chikai Black 18 neurovascular guidewire in the treatment of intracranial large vessel occlusive stroke. This will be compared to a historical control that will include the prior 50 consecutive patients fitting the same selection criteria.
This is a prospective registry collecting information on 50 patients treated with the ASAHI
Chikai Black 18 microguidewire. Patients will undergo mechanical thrombectomy for acute large
vessel occlusive stroke within the anterior circulation as is standard of care.
Additionally, this study will have a retrospective portion which will examine 50 consecutive
patients who meet inclusion/exclusion criteria treated for acute anterior circulation large
vessel occlusive stroke prior to the initiation of the Sure -18 Registry. This retrospective
cohort will be 50 consecutive mechanical thrombectomy cases performed using any neurovascular
microguidewire other than the device under study (Asahi Chikai Black 18) at the same
enrolling centers leading up to December 10, 2018.
;